Neurodegenerative diseases (NDs) such as Alzheimer's Disease (AD) and Parkinson's
Disease (PD) are devastating conditions that can develop without noticeable symptoms …

The high failure rate of clinical trials in Alzheimer's disease (AD) and AD-related dementia
(ADRD) is due to a lack of understanding of the pathophysiology of disease, and this deficit …

With the progress and innovation of science and technology, virtual reality technology
emerges as the times require, and its application in digital media art creation is more and …

The subjectivity and inaccuracy of in-clinic Cognitive Health Assessments (CHA) have led
many researchers to explore ways to automate the process to make it more objective and to …

Virtual Reality (VR) technologies have increasingly been considered potentially valuable
tools in dementia-related research and could serve as non-pharmacological therapy to …

Background Early detection of mild cognitive impairment (MCI), a transitional stage between
normal aging and Alzheimer disease, is crucial for preventing the progression of dementia …

Background Cognitive disorders, such as Alzheimer's disease, are a global health problem.
Digital healthcare technology is an innovative management tool for delaying the progression …

Neurologists nowadays no longer view neurodegenerative diseases, like Parkinson's and
Alzheimer's disease, as single entities, but rather as a spectrum of multifaceted symptoms …

Objetivo. Este trabajo tiene como objetivo proporcionar una revisión y una actualización de
los criterios diagnósticos de deterioro cognitivo objetivo para su uso en el DCL y la …

Background With the global rise in Alzheimer disease (AD), early screening for mild
cognitive impairment (MCI), which is a preclinical stage of AD, is of paramount importance …